Yarrow Bioscience S-4 Filing for Shanghai Scizeng Deal

Yarrow Bioscience, Inc. filed an S-4 that includes an exhibit describing a confidential exclusive license agreement with Shanghai Scizeng Medical Technology Co., Ltd. as licensor. The exhibit lists multiple parties as guarantors.

The agreement outlines license grants, governance via a joint steering committee, development and regulatory responsibilities, supply and manufacturing/technology transfer provisions, commercialization diligence, and financial terms including upfront payment, milestone payments, and royalty payments. It also covers intellectual property prosecution and enforcement, confidentiality obligations, indemnification, term and termination, and dispute resolution including binding arbitration.